Table 1.
Baseline characteristics.
| Variable | (mean±SD) |
|---|---|
| Age, y | 36.05 ± 2.2 |
| Sex | |
| woman (N, %) | 32 (69.6%) |
| man (N, %) | 14 (30.4%) |
| WBC (10^3/uL) | 7.3 ± 1.7 |
| RBC (10^6/uL) | 4.8 ± 0.4 |
| Hgb (g/dL) | 14.1 ± 1.3 |
| HCT (%) | 42.8 ± 3.4 |
| MCV (fL) | 90.3 ± 4.3 |
| MCHC (g/dL) | 32.8 ± 0.9 |
| MCH (pg) | 29.6 ± 1.5 |
| PLT (10^3/uL) | 250.1 ± 51.7 |
| Neutrophils (10^3/uL) | 4.3 ± 1.5 |
| Basophils (10^3/uL) | 0.04 ± 0.02 |
| Eosinophils (10^3/uL) | 0.1 ± 0.1 |
| Lymphocytes (10^3/uL) | 2.3 ± 0.6 |
| Monocytes (10^3/uL) | 0.5 ± 0.1 |
| N reported previous SARS-CoV-2 Infection (2020 pandemic) | 3 (EXCLUDED) |
| N undoubted previous SARS-CoV-2 Infection, IgG+-based | 1 |
| N Infection during the vaccination | 1 |
WBC, whole blood cell; RBC, red blood cell; Hgb, hemoglobin; HCT, hematocrit; MCV, mean corpuscular value; MCHC, mean corpuscular hemoglobin concentration; MHC, mean corpuscular hemoglobin; PLT, platelets.